ATP Assays Market Size, Share and Industry Analysis 2027

ATP Assays Market Outlook – 2027

Variety of enzymatic reactions makes use of ATP which helps in maintain daily life activities. When cells undergo apoptosis and necrosis, a change occurs in the ATP characteristics. This is the reason behind ATP been used on such a broad scale as valid marker of viable cells. ATP are generally measured by firefly luciferase method which is consider to be the most applied method for approximate number of viable cells.

ATP Assays Market

The ATP assay makes use of luciferase which helps in catalyzing the formation of light from D-luciferin and ATP, which is measured with the help of aluminometer or Beta Counter. The main advantage of ATP assay is that the researcher does not have to rely on an incubation step with viable cells population to convert a substrate to a colored compound. Cell culture medium need not be removed or washing the cells before adding the reagent, which can be fully automatic for high throughput.

COVID-19 scenario analysis:

Pharmaceutical and biotech companies together with governments around the globe are working to address the COVID-19 outbreak, from supporting the development of vaccines to planning for medicines supply chain challenges. Currently, around 115 vaccine candidates and 155 molecules are in the R&D pipeline. Moreover, commonly used drugs such as Hydroxychloroquine have witnessed a dramatic surge in demand for the management of COVID-19. Such high demand for these drugs has presented huge opportunities for manufacturers of COVID-19 management drugs, as many developed countries are short of these drugs. Owing to the demand for vaccine and treatment drugs for COVID-19, the pharmaceutical and biotechnology industry is expected to witness a significant growth in the future.

Owing to such factors, COVID 19 is expected to have a significant impact on the ATP Assays market.

Top impacting factors: Market Scenario Analysis, Trends, Drivers and Impact Analysis:

Constantly rising demand for ATP assays in pharmaceutical and biotechnology companies, there is also a significant increase in pharmaceutical and biotechnology R&D, increasing frequency of cancer, chronic and other infectious diseases and a shift from culture-based tests to rapid tests are the major driving factors of ATP assays market.

Alongside, ATP assaysare also been used to higherthemicrobial contamination testing forthe healthcare sector and the growing applications of ATP assays.

On the other hand, very expensive instruments are the biggest challenge for the marker and are restraining the growth of the ATP assays industry to a certain extent.

New product launches and acquisitions to flourish the market:

On March 12^th, 2019, Promega launched the Water-Glo reagent which will be used bioluminescent technology to measure the ATP and additionally monitoring microbial contamination in freshwater, process water, seawater, or wastewater samples can be done using this reagent.

On August 6^th, 2018, Hygiena acquired Biomedal’s Food Safety divisionandrenamed it to Hygiena Diagnóstica España which now provides tests for allergen and assays.

On February 16^th, 2018, Merck invested around USD 44 million andexpandedtheir manufacturing and distribution centres in India, South Korea, and China.

On August 18th, 2017, Hach which is a subsidiary of Danaher Corporation and this helped them expand in Loveland, US campus by starting a new facility for R&D.

Surge in usage in Pharmaceutical & biotechnology company’s applications:

Biotechnology and pharmaceutical companies, hospitals & diagnostic laboratories, food & beverage industry,and academic andresearch institutions are the major consumers of ATP assays. The biotechnology and pharmaceutical companies are the biggestmarket consumers amongst them. Adoption of the ATP assays is very high in biotechnology and pharmaceutical companies is done for the accounts of contamination testing.

Key benefits of the report:

This study presents the analytical depiction of the global ATP Assays industry along with the current trends and future estimations to determine the imminent investment pockets.
The report presents information related to key drivers, restraints, and opportunities along with detailed analysis of the global ATP Assays market share.
The current market is quantitatively analyzed to highlight the global ATP Assays market growth scenario.
Porter’s five forces analysis illustrates the potency of buyers & suppliers in the market.
The report provides a detailed global ATP Assays market analysis based on competitive intensity and how the competition will take shape in coming years.

Questions answered in the ATP Assays Market research report:

What are the leading market players active in the ATP Assays market?
What the current trends will influence the market in the next few years?
What are the driving factors, restraints, and opportunities in the market?
What are the projections for the future that would help in taking further strategic steps?

ATP Assays Market Report Highlights

Aspects	Details
By Product	Consumables and Accessories Reagents and Kits Microplates Other Consumables & Accessories Instruments Luminometers Spectrophotometers
By Application	Contamination Testing Disease Testing Drug Discovery and Development
By End User	Pharmaceutical and Biotechnology Companies Food and Beverage Industry Hospitals and Diagnostics Laboratories Academic and Research Institutions
By Region	North America (U.S., Canada, Mexico) Europe (France, Germany, Italy, Spain, UK, Rest of Europe) Asia-Pacific (China, Japan, India, South Korea, Australia, Rest of Asia-Pacific) LAMEA (Brazil, South Africa, Saudi Arabia, Rest of LAMEA)
Key Market Players	Promega Corporation, MerckKGaA, BioThema AB., Abcam plc., Danaher Corporation, PerkinElmer, Inc., Thermo Fisher Scientific, Inc., Lonza Group, Agilent Technologies, Inc., Hygiena, LLC.